Jilin Province Huinan Changlong Bio-pharmacy Ltd 2024 Sustainability Report
Company: Jilin Province Huinan Changlong Bio-pharmacy Ltd
Sector: Manufacturing
Country: Hong Kong
Year: 2024
Type: Sustainability Report
Pages: 24
The report explains that the Board retains overall responsibility for the Group’s ESG issues and that management supports ESG data collection and performance monitoring. It reports a materiality review covering 18 ESG issues, with occupational health and safety and product and service responsibility identified as the most important issues. For 2024, Scope 1 and Scope 2 GHG emissions totaled 111,878 tCO2e, while total energy consumption was 96,874 MWh. The Group had 745 employees at year-end and reported no work-related deaths during the reporting period.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.